The expression of the transcription factor Oct-4 is thought to be one of the decisive factors that maintain totipotency in embryonic and germ cells. In mice, oct-4 is exclusively expressed in germ cells and totipotent cells of the embryo. In humans, Oct-4 is expressed in germ cells, embryonic stem cells and whole embryos at various stages of development. However, there is limited information about the distribution of Oct-4 expression in human embryos. In an attempt to address this issue, the inner cell mass (ICM) and trophectoderm (TE) of 17 human blastocysts were separated and Oct-4 mRNA expression individually assessed by reverse transcription-polymerase chain reaction (RT-PCR). In discarded blastocysts that developed from two pronuclear zygotes, the mean Oct-4 expression was 31 times higher in totipotent ICM cells than in differentiated TE cells. This finding suggests that, in accordance with data from the mouse, Oct-4 is highly expressed in human ICM cells as opposed to TE cells; this in turn supports the hypothesis that Oct-4 plays a similar role to maintain totipotency in these two species.
Introduction
Oct-4 is proposed to be one of the key factors that allows cells to remain in the cycle of totipotency: some totipotent Oct-4, also named Oct-3 (Scholer et al., 1990; Okamoto et al., embryonic cells form totipotent germ cells, which in turn give 1990; Rosner et al., 1990) , is a transcription factor which rise to new totipotent embryonic cells after fertilization. In belongs to the POU (Pit, Oct, Unc) family of domain transcripmice, oct-4 is immediately down-regulated after cell differtion factors. Oct-4 belongs to the sub-group of octamer-binding entiation (Palmieri et al., 1994) ; oct-4 has also been shown to proteins which bind by the POU domain to promoter and be essential for the development of pluripotent inner cell mass enhancer regions of various genes. Almost all POU domain (ICM) cells in murine embryogenesis (Nichols et al., 1998) . transcription factors are developmentally-regulated in mice.
In an attempt to clarify the distribution pattern of Oct-4 in In humans, Oct-4 is the product of the OTF3 gene, which human embryos, Oct-4 mRNA expression was assessed by consists of five exons and is located on chromosome 6 near RT-PCR in the ICM and TE of blastocysts. In accordance the major histocompatability complex (MHC) (Takeda et al., with the hypothesis established in mice, a high expression in 1992; Abdel-Rahman et al., 1995) . It encodes two splicing totipotent ICM cells and a low expression in differentiated TE variants, one of which shares 87% sequence identity with cells was found. mouse oct-4 (Takeda et al., 1992) . In addition to the OTF3 gene, there is a related OTF3C gene which is a retroposon and localized at chromosome 8 (Takeda et al., 1992) .
In mice, oct-4 is exclusively found in totipotent embryonic
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cells and germ cells (Palmieri et al., 1994) . While not found 10 of development (van Eijk et al., 1999) . In humans, Oct-4 retrieval to fertilization check the next day (day 1) the embryos were is present throughout all stages from the unfertilized oocyte cultured in human tubal fluid medium (HTF; Irvine Scientific, Santa to blastocysts, as detected by reverse transcription-polymerase Ana, CA, USA), then transferred to G1.2 or HTF media from days chain reaction (RT-PCR) (Abdel-Rahman et al., 1995) and by 1 to 3 and to G2.2 from day 3 to 7 (IVF Science Scandinavia, PCR of cDNA libraries (Verlinsky et al., 1998) . Oct-4 is also (Rosner et al., 1990) as well as in media. Blastocysts were chosen for experiments when the ICM was human embryonal carcinoma (EC) cells (Pera and Herszfeld, clearly distinguishable from the TE. Selected blastocysts formed late after 6 or more days of culture and displayed an anomalous morpho-1998) and murine EC cells (Okamoto et al., 1990) . logy indicating a poor prognosis for pregnancy outcome. As such to avoid DNA contamination of the RNA pellet. The RNA was washed with 70% ethanol, solved in 20 µl DEPC water, transferred they were appropriate for use in an Institutional Review Boardapproved study (H-6902) to develop genetic procedures using disto a fresh tube, and precipitated with 140 mmol/l NaAc and 60 µl 100% ethanol at 4°C overnight. carded IVF tissues.
Isolation of trophectoderm and ICM cDNA synthesis
The RNA was resolved in 1.9 µl DEPC water, 0.2 µg random oligo Blastocysts were transferred to a preincubated fresh drop of G2.2 media and placed under a micromanipulator (Nikon Narishige, Tokyo, primer and 1 µl 10ϫ reaction buffer (SuperScript Preamplification System; Life Technologies, Rockville, MD, USA) and heated to 70°C Japan). Blastocysts were then halved by means of a razorblade fragment attached to the micromanipulator by a plastic pipe. A second for 5 min. Samples were then placed on ice, centrifuged and 2.6 µl of a mix of 2.5 mmol/l MgCl 2 , 10 mmol/l dithiothreitol, 0.5 mmol/l pipette was used to navigate the embryo. Great care was taken to avoid any ICM cell contamination in the TE fraction by leaving some NTP and 5 IU RNAse inhibitor (Promega, Madison, WI, USA) added. After incubation for 10 min at room temperature 100 IU Superscript II space between the ICM cells and the cut and by washing the razorblade with 70% ethanol after each dissection. The razorblade Reverse Transcriptase were pipetted to the sample and the cDNA synthesis carried out at room temperature for 5 min and 42°C for was moved back and forth several times until the two halves appeared totally separated (Figures 1 and 2) . The ICM and TE halves were 50 min. The reaction was stopped at 95°C for 5 min. DNA content and purity was determined by spectrophotometric analysis of then moved to different parts of the drop by the pipette and sucked individually into a suction pipette. The suction pipette was preloaded 0.3 µl diluted in 50 µl H 2 O (Beckman DU-600). with 4 mol/l guanidium isothiocyanate (GuSCN) denaturing solution PCR which was separated from the media by an air bubble; different pipettes were used for each half. The suction pipette with the ICM The first PCR for Oct-4 was carried out with 400 ng cDNA template, 50 nmol/l modified outer primer (Abdel-Rahman et al., or TE fraction was then removed from the pipette holder of the micromanipulator and the entire content flushed several times into a 1995) consisting of 3Ј primer GGAAAGGCTTCCCCCTCAGGG-AAAGG and 5Ј primer AAGAACATGTGTAAGCTGCGGCCC), tube containing 100 µl 4 mol/l GuSCN, 0.5% sarcosyl, 20 µl ribosomal RNA (Roche Diagnostics, Mannheim, Germany) and 1% β mercapto-6 µmol/l NTP (Life Technologies) and 2 mmol/l MgCl 2 . The second nested PCR used 2 µl of the first PCR, 500 nmol/l modified ethanol denaturing solution. One blastocyst with no ICM ('empty blastocyst') was directly sucked by the suction pipette and transferred inner primer consisting of 3Ј primer TTCTGGCGCCGGTTACA-GAACCA and 5Ј primer GACAACAATGAGAACCTTCAGGAGA, to the denaturing solution without any manipulation ( Figure 3 ). Some media samples were saved as negative controls for the PCR.
20 µmol/l NTP and 2 mmol/l MgCl 2 . Both PCRs used a 'hot start' with 1 IU Taq DNA polymerase (Roche Diagnostics) at 94°C for RNA isolation 4 min followed by 20 cycles (first PCR) or 30 cycles (second PCR) of 94°C for 15 s, 62°C for 30 s, and 72°C for 30 s in a GeneAmp RNA isolation was carried out as described (Rappolee et al., 1989) . Briefly, the lysate in the GuSCN denaturing solution was laid over 9600 (Perkin Elmer, Norwalk, CT, USA). Final extension was 72°C for 10 min. Positive control reactions for β-actin were routinely 100 µl of 5.7 mol/l caesium chloride and centrifuged in a Optima TL tabletop ultracentrifuge with a TLA 100.4 rotor (Beckman Coulter, carried out as the first PCR for Oct-4 with 0.2 µl template except for 50 cycles instead of 20 (3Ј primer CGTGGGGCGCCCCAGGCACCA, Fullerton, CA, USA) for 3.5 h at 204 000 g. The supernatant was then removed in several 50 µl steps with new pipette tips each time 5Ј primer TTGGCCTTGGGGTTCAGGGGGG). Water and media Figure 2 ) (0PN), 12 ϭ on a 2% agarose gel with 0.5ϫ Tris/borate/EDTA (TBE) buffer. The TE embryo no. VI; lane 13 ϭ empty blastocyst no. VII (shown in usual precautions to avoid contamination were followed. A 50 bp Figure 3 ); lane 14 ϭ water control; lane 15 ϭ media control. Both ICM and TE fractions with 400 ng template each were subjected to ladder marker (100 ng, marker XIII, Roche Diagnostics) was routinely the same polymerase chain reaction (PCR) conditions in the same used as reference to estimate PCR product size.
experiment. Oct-4 nested PCR product ϭ 218bp. (b) β-actin control reactions for the blastocysts I-VII corresponding to (a); 0.2 µl Titration template for each reaction. β-actin product ϭ 243 bp. (c) In a first titration, 400-25 ng (ICM) or 400-2400 ng (TE) were Computerized analysis of relative expression levels of Oct-4 mRNA subjected to the above-described PCR conditions to determine the in the ICM fractions of the blastocysts I-VI. y axis shows factor by sensitivity of the PCR and the relative expression levels of Oct-4 in which Oct-4 expression differs from the mean value (ϭ 1) of all ICM and TE fractions. In a second titration, a more sensitive PCR six blastocysts. All gels: 2% agarose gel, 0.5ϫ Tris/borate/EDTA with 500 nmol/l outer primer, 40 µmol/l NTP and 50 cycles in the (TBE) buffer, 10 µl PCR product loaded, 50bp ladder marker. first PCR and 500 mmol/l inner primer, 20 µmol/l NTP and 25 cycles in the second PCR, was applied to 1060-2 ng of ICM and TE blastocysts from 3PN zygotes and one from a 0PN zygote fractions to confirm relative expression levels. all embryo samples; control reactions for water and media were negative (Figure 4b ).
Software analysis of PCR bands
In the nested PCR 455bp products of the first round (data PCR bands were analysed by a GelDoc 2000 system with Quantity not shown) were subjected to the second round and yielded 
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GG/CC (Figure 5).
Oct-4 expression levels were compared between ICM and In all, 18 blastocysts were examined for Oct-4 expression: 14 blastocysts originated from 2PN zygotes (Figure 1) , two TE cells of 4 blastocysts (Figure 6 ). The sensitivity limit (up signal despite a small number of ICM cells (~8). Similar variations for β-actin mRNA were not observed because the PCR presumably reached a plateau for all reactions after 50 cycles. While the ICM of the 0PN blastocyst showed a relative 1.37 fold increase in Oct-4 mRNA levels compared to the mean value for other ICM samples (Figure 4) , the 3PN blastocyst exhibited a relative decrease of 0.76-fold. This was also true for another 3PN blastocyst with a 0.88-fold decrease in relative expression. The empty blastocyst did not show an Oct-4 signal with the applied PCR conditions (Figures 3  and 4a ). trophectoderm cells when these blastocysts were bisected, this 31-fold difference may well be a minimum value which is slightly higher in reality. Since all TE fractions were positive to 33 ng in ICM) was determined for both fractions as being approximately the median between the last positive and the for β-actin expression, their negative signals in the Oct-4 PCR were not due to failure of cDNA synthesis. Positive β-actin first negative value. The ICM sensitivity limit was then compared with the TE sensitivity limit. The Oct-4 level was, mRNA signals also ensured that the RNA was not severely degraded during the process of cutting the embryo. Negative on average, 34-fold higher in ICM compared with that in TE fractions (range: 32ϫ to 37ϫ; Figure 6a and data not shown).
Discussion
water and media controls ensured the absence of Oct-4 and β-actin contamination. All experiments were repeated and the The relative expression levels were confirmed with the same four blastocysts in a highly sensitive PCR (down to 8 ng) with results confirmed. The variation of Oct-4 mRNA levels between ICM and TE Oct-4 being, at an average, 29 times higher in ICM than in TE fractions (range: 21ϫ to 33ϫ; Figure 6b and data not fractions were established by two titration studies. Since the titrations were standardized to absolute amounts of cDNA shown). Taking both titration PCRs together, the Oct-4 mRNA level was 31 times higher in ICM cells than in TE cells (range:
template, (small) differences in the cell number of the ICM and TE fractions tested should not have played a role. Although 21ϫ to 37ϫ).
Computerized analysis of the bands on the gel revealed displaying different Oct-4 mRNA levels in the ICM fractions, all four blastocysts examined generated a very similar induction transcription factor levels in mice (Brehm et al., 1997) , which supports the hypothesis of an initial high level of oct-4 with factor between ICM and TE cells, varying only by a maximum of 1.8-fold. Also the differences between the two titration a subsequent down-regulation in mammalian embryogenesis. In human oocytes, Oct-4 is also abundant (C.Hansis; unpublished PCRs, the second being 4.1 times more sensitive, are minimal with 28ϫ induction of Oct-4 for the second, compared with data). So far, approximately nine known and several unknown genes have been found to contain Oct-4 binding sites, some 34ϫ for the first, PCR.
The variations in Oct-4 mRNA levels in the ICM of the of them being positively and negatively regulated by Oct-4 (Ovitt and Scholer, 1998) such as repression of α and β subunits blastocysts from 2PN zygotes were well correlated with the size of the ICM; i.e. the more ICM cells, the more total Oct-4 of human chorionic gonadotrophin (HCG) and activation of the platelet-derived growth factor (PDGF) α receptor. was detected. According to these observations, the levels in each individual ICM cell would appear to be rather similar.
An abnormal pronuclear status does not seem to prevent ICM cells from expressing Oct-4. Since the embryo diagnosed This hypothesis agrees with the recent findings (Niwa et al., 2000) that describe the close regulation of Oct-4 expression as 0PN at day 1 still developed into a blastocyst, it should have contained chromosomes and experienced the genetic in murine ES cells. A relative expression level of 0.5, 1.0 and 1.5 was found to direct the cells to trophectoderm, ICM and activation around the 4-cell stage that is required for further embryonic development. Zygotes with 0PN rarely develop into primitive endoderm and mesoderm respectively. In contrast, our results differ from recent findings that describe oct-4 a blastocyst in our IVF programme; however, it is possible that the pronuclei were missed during the fertilization check expression in bovine embryos at a similar level in both ICM and TE cells until day 10 of embryonic development (van Eijk due to an abnormal timing of pronuclear formation. Significantly, Oct-4 mRNA was not detected in an 'empty et al., 1999) .
The 3PN blastocysts showed a decreased relative level of blastocyst' lacking an ICM. One elegant explanation for such a blastocyst is that Oct-4 expression in the ICM progenitor Oct-4 mRNA compared with 2PN blastocysts, while the 0PN blastocyst exhibited increased level. This finding is rather blastomeres is disturbed and a proper ICM cannot be formed. Such a hypothesis is based on murine studies in which unexpected since one would assume that an extra copy of all chromosomes leads to an increased Oct-4 expression while pluripotent ICM formation was shown to depend on Oct-4 expression (Nichols et al., 1998) . loss of chromosomes results in decreased expression. An explanation could be that transcription factors, which regulate The 31-fold higher level of Oct-4 mRNA expression in the ICM fraction, compared with the TE fraction, of human 2PN Oct-4 in a negative way, are over-expressed by an additional set of chromosomes.
blastocysts is a strong indication that Oct-4 has a similar function in retaining totipotency as has been established in Information about oct-4 repression is limited and seems to involve a retinoic acid responsive element (Pikarsky et al., murine cells (Pesce et al., 1998) . Nevertheless, more proof is needed that the biological function of Oct-4 is the same in 1994). Other described mechanisms, e.g. changes in chromatin structure (Minucci et al., 1996) and de-novo methylation humans and mice. As in mice, a high Oct-4 expression could allow human ICM cells to remain totipotent, while Oct-4 (Ben- Shushan et al., 1993) could also be induced by overexpression of the responsible genes. The question of which down-regulation would initiate differentiation into TE cells. Oct-4 is also detectable in human TE cells, but this might be physiological processes trigger Oct-4 down-regulation is still open; several hypotheses are discussed including the location due to a low background expression or slowly declining Oct-4 mRNA levels in newly differentiated cells. of cells in the embryo and formation of specific cell-cell contacts, e.g. a signal cascade from E-cadherin to β-catenin to These experiments establish for the first time the relative differences in Oct-4 expression between human ICM and TE lymphoid enhancer factor (LEF-1) (Pesce et al., 1998) .
Candidate genes for the activation of Oct-4 expression are cells. Oct-4 might thus play a similar role to maintain totipotency in humans as it does in mice. Consistent with the the transcription factors Sp1 and Sp3 (Sylvester and Scholer, 1994; Pesce et al., 1999) and SF1 (Barnea and Bergman presented data, Oct-4 expression was recently detected in ICMderived human ES cells (Reubinoff et al., 2000) . In the future, 2000). Oct-4 activation occurs prior to any changes in known van Eijk, M.J., van Rooijen, M.A., Modina, S. et al. (1999) 
